Bio Tech & Pharma Principal Technologies Extends Private Placement Closing DateBy Alexander LeeAugust 17, 20240 Professor Dana Rizk, an Investigator and APPLAUSE-IgAN Steering Committee Member at the University of Alabama at Birmingham Division of Nephrology,…
Bio Tech & Pharma Patients with Rett Syndrome Demonstrate Continued Clinical Progression Following 20-Week NTI164 TreatmentBy Alexander LeeAugust 17, 20240 The complex and progressive nature of IgA nephropathy poses challenges in its effective treatment, but the landscape of therapies is…
Bio Tech & Pharma Positive Phase 2a Fibromyalgia Study Demonstrates Pain Reduction in All Subjects, Enhancing Intellectual Property and Clinical Trial Approach.By Alexander LeeAugust 17, 20240 The Phase 1a trial of SZN-043 has shown evidence of target engagement and Wnt-pathway mediated pharmacodynamic effects in the liver.…
